REGN
#205
Regeneron Pharmaceuticals, Inc. - Common Stock
779.2 7 USD
+0.03%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+3.47%
Changement Mensuel
-1.17%
Evolution sur 6 mois
+2.72%
Changement Annuel
+35.52%
Clôture Précédente
753.1 2
Open
758.0 8
Low
755.2 1
High
781.8 4
Financials
- Market Capitalization 80.23 B
- Employee 15 K
- Founded 1988
- CEO Leonard Schleifer
- Website www.regeneron.com
- Headquarter New York, United States
- FIGI BBG000C734W3
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
18.61
ratio cours/chiffre d'affaires
5.84
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 119 |  VRTX Vertex Pharmaceuticals Incorporated - Common Stock | 498.50 USD | +2.74% | -1.41% | -4.10% | +20.95% | 126.35 B USD | ||
| 181 |  MRNA Moderna, Inc. - Common Stock | 226.35 USD | +4.67% | +15.24% | +55.03% | +752.86% | 90.37 B USD | ||
| 307 |  ARGX argenx SE - American Depositary Shares | 818.08 USD | +1.92% | -11.89% | -17.02% | +2.27% | 50.63 B USD | ||
| 355 |  RVMD Revolution Medicines, Inc. - Common Stock | 193.74 USD | +2.81% | -3.55% | -6.40% | +249.71% | 41.53 B USD |